Elanco Animal Health Capital Expenditures (CapEx) Growth & History (ELAN)
Elanco Animal Health's capital expenditures (capex) was $276.0M for fiscal 2025.
View full Elanco Animal Health company overviewElanco Animal Health annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $276.0M | $129.0M | +87.76% |
| 2024 | 2024-12-31 | $147.0M | $7.0M | +5.00% |
| 2023 | 2023-12-31 | $140.0M | −$31.0M | −18.13% |
| 2022 | 2022-12-31 | $171.0M | $12.0M | +7.55% |
| 2021 | 2021-12-31 | $159.0M | $24.0M | +17.78% |
| 2020 | 2020-12-31 | $135.0M | −$5.0M | −3.57% |
| 2019 | 2019-12-31 | $140.0M | $5.5M | +4.09% |
| 2018 | 2018-12-31 | $134.5M | $35.9M | +36.41% |
| 2017 | 2017-12-31 | $98.6M | −$11.7M | −10.61% |
| 2016 | 2016-12-31 | $110.3M | — | — |
Elanco Animal Health quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $33.0M | −$24.0M | −42.11% |
| Q1 2026 | 2026-03-31 | $51.0M | −$14.0M | −21.54% |
| Q4 2025 | 2025-12-31 | $62.0M | $15.0M | +31.91% |
| Q3 2025 | 2025-09-30 | $92.0M | $50.0M | +119.05% |
| Q2 2025 | 2025-06-30 | $57.0M | $23.0M | +67.65% |
| Q1 2025 | 2025-03-31 | $65.0M | $41.0M | +170.83% |
| Q4 2024 | 2024-12-31 | $47.0M | $6.0M | +14.63% |
| Q3 2024 | 2024-09-30 | $42.0M | $9.0M | +27.27% |
| Q2 2024 | 2024-06-30 | $34.0M | −$8.0M | −19.05% |
| Q1 2024 | 2024-03-31 | $24.0M | $0 | 0.00% |
| Q4 2023 | 2023-12-31 | $41.0M | −$59.0M | −59.00% |
| Q3 2023 | 2023-09-30 | $33.0M | $7.0M | +26.92% |
| Q2 2023 | 2023-06-30 | $42.0M | $16.0M | +61.54% |
| Q1 2023 | 2023-03-31 | $24.0M | $5.0M | +26.32% |
| Q4 2022 | 2022-12-31 | $100.0M | $1.0M | +1.01% |
| Q3 2022 | 2022-09-30 | $26.0M | $1.0M | +4.00% |
| Q2 2022 | 2022-06-30 | $26.0M | $9.0M | +52.94% |
| Q1 2022 | 2022-03-31 | $19.0M | $1.0M | +5.56% |
| Q4 2021 | 2021-12-31 | $99.0M | $8.0M | +8.79% |
| Q3 2021 | 2021-09-30 | $25.0M | $22.0M | +733.33% |
| Q2 2021 | 2021-06-30 | $17.0M | −$11.0M | −39.29% |
| Q1 2021 | 2021-03-31 | $18.0M | $5.0M | +38.46% |
| Q4 2020 | 2020-12-31 | $91.0M | $800,000 | +0.89% |
| Q3 2020 | 2020-09-30 | $3.0M | $1.0M | +50.00% |
| Q2 2020 | 2020-06-30 | $28.0M | $4.2M | +17.65% |
| Q1 2020 | 2020-03-31 | $13.0M | −$15.0M | −53.57% |
| Q4 2019 | 2019-12-31 | $90.2M | $30.0M | +49.83% |
| Q3 2019 | 2019-09-30 | $2.0M | −$15.8M | −88.76% |
| Q2 2019 | 2019-06-30 | $23.8M | $0 | 0.00% |
| Q1 2019 | 2019-03-31 | $28.0M | −$4.7M | −14.37% |
| Q4 2018 | 2018-12-31 | $60.2M | — | — |
| Q3 2018 | 2018-09-30 | $17.8M | — | — |
| Q2 2018 | 2018-06-30 | $23.8M | — | — |
| Q1 2018 | 2018-03-31 | $32.7M | — | — |
Elanco Animal Health capital expenditures (capex) trends
Over the last five fiscal years, Elanco Animal Health's capital expenditures (capex) increased from $135.0M to $276.0M, a change of $141.0M. The latest reported quarter, Q2 2026, shows $33.0M.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Elanco Animal Health source filings ↗